1.
J Pediatr Endocrinol Metab
; 28(3-4): 439-41, 2015 Mar.
Artículo
en Inglés
| MEDLINE
| ID: mdl-25210761
RESUMEN
L-asparaginase (L-Asp) is an essential component of acute lymphoblastic leukemia (ALL) treatment protocols and its use has been associated with many adverse effects. We report a case of a 15-year-old boy with ALL who developed L-Asp induced hypoglycemia. To the best of our knowledge, only one such case has been reported previously.
